The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer

Terzioglu-Usak, SuleHorozoglu, CemDemirkol, SeydaTurna, AkifYaylim, Ilhan2021-05-252021-05-252021-04-01Terzioglu-Usak S., Horozoglu C., Demirkol S., Turna A., Yaylim I., -The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer-, TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.29, sa.2, ss.212-222, 2021http://hdl.handle.net/20.500.12645/28922Background: The aim of this study was to investigate the possible relationship between galectin-3 gene variants, serum level, gene expression level, and the risks and survivals of resectable non-small cell lung cancer patients.The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancerArticleWOS:00064519710001110.5606/tgkdc.dergisi.2021.2014134104515